Trimetazidine protects against smoking-induced left ventricular remodeling via attenuating oxidative stress, apoptosis, and inflammation.
作者:
主题词
动物(Animals);细胞凋亡(Apoptosis);心肌疾病(Cardiomyopathies);强心药(Cardiotonic Agents);细胞因子类(Cytokines);药物评价, 临床前(Drug Evaluation, Preclinical);基因表达调控(Gene Expression Regulation);炎症(Inflammation);炎症介导素类(Inflammation Mediators);男(雄)性(Male);肌细胞, 心脏(Myocytes, Cardiac);氧化性应激(Oxidative Stress);大鼠(Rats);大鼠, Wistar(Rats, Wistar);吸烟(Smoking);曲美他嗪(Trimetazidine);血管舒张药(Vasodilator Agents);心室重构(Ventricular Remodeling)
DOI
10.1371/journal.pone.0040424
PMID
22792312
发布时间
2021-10-21
- 浏览28
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文